By OLIVER SAMBOKOZambia is to commence clinical trials of ivermectin, an anti-parasitic drug for the treatment and prevention of Covid-19.Ivermectin will only be used in approved clinical trials where participants will be closely monitored and generated evidence shall inform policy on the prevention or treatment of COVID-19; after which members of the public will be informed of the outcomes. A statement from the Medicines Regulatory Authority (ZAMRA) has allowed clinical trials to study the efficacy of the drug which is already under study in neighbouring Zimbabwe and other countries overseas.Zimbabwe has already approved the mass importation of the veterinary anti-parasitic drug for treatment of COVID 19 patients. This follows that country’s Ministry of Health directive to the Medicines Control Authority of Zimbabwe (MCAZ) to approve the use of Ivermectin in the treatment of COVID-19.ZAMRA Senior Public relations Officer Christabel Mutale Iliamupu said in a statement that the decision to undertake the study comes after the continued […]
Clinical trials to start for use of Ivermectin to treat covid-19
